𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibody manufacturing in transgenic plants — myths and realities

✍ Scribed by Elizabeth E Hood; Susan L Woodard; Michael E Horn


Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
67 KB
Volume
13
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

✦ Synopsis


The number and types of antibodies expressed in plants has increased steadily since the first reports of this accomplishment in the 1980s, illustrating the versatility of plants as a production system for antibodies. Many recent reviews have detailed the antibody forms that have been derived from plant expression systems. This contribution focuses on the remaining challenges to develop plant-derived therapeutic antibodies into products, and some of the progress that is being made in addressing these challenges.


📜 SIMILAR VOLUMES


Antibody manufacture in transgenic anima
✍ Louis-Marie Houdebine 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Various forms of recombinant monoclonal antibodies are being used increasingly, mainly for therapeutic purposes. The isolation and engineering of the corresponding genes is becoming less of a bottleneck in the process; however, the production of recombinant antibodies is itself a limiting factor and

Production of a diagnostic monoclonal an
✍ Habib Khoudi; Serge Laberge; Jean-Marc Ferullo; Renée Bazin; André Darveau; Yves 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

The increasing use of monoclonal antibodies (mAbs) in diagnostic reagents necessitates efficient and cost-effective mAb production methods. In blood banks, one of the most routinely used reagents is the antihuman IgG reagent used for the detection of nonagglutinating antibodies. Here we report the p